First-in-Human Trial Shows Synthetic Immune Cell Activator IMM60 Is Safe in Advanced Cancer
A first-in-human phase I trial found that the liposomal iNKT cell agonist IMM60, given alone or with pembrolizumab, was well ...
Tag: Immune system activation
UCLA Researchers Win NIH Grant to Improve Cancer Immunotherapy Effectiveness
Dr. Cristina Puig-Saus and her research team at the UCLA Health Jonsson Comprehensive Cancer Center have received a five-year, $3.9 ...
Needle-Free Vaccine Delivery Achieved in Mice Through Skin Stretching Technique
In a breakthrough that could revolutionize vaccine administration, researchers have discovered that mechanically stretching the skin significantly enhances its permeability ...
Breakthrough Cancer Drug Eradicates Aggressive Tumors in Clinical Trial
Over the last two decades, CD40 agonist antibodies have emerged as a beacon of hope in cancer immunotherapy, promising to ...
Precision Tumor Targeting with Multi-Epitope Nanoparticles
In the ever-evolving battle against cancer, a revolutionary approach has emerged, promising to elevate the precision and efficacy of immunotherapy ...
Blocking NAT10 Boosts Antitumor Immunity via MYC Pathway
In a groundbreaking study published in Nature Communications, researchers have uncovered a novel mechanism by which the inhibition of tumor-intrinsic ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!